SS Innovations International (NASDAQ: SSII) will demonstrate its SSi Mantra surgical robotic system at the Society of Robotic Surgery (SRS) 2026 Annual Meeting, scheduled for July 23-26 in Hollywood, Florida. The event, one of the largest gatherings of robotic surgery specialists, will feature a live telesurgery broadcast from India in which a partial nephrectomy will be performed remotely using the SSi Mantra platform. The demonstration aims to highlight the system's remote surgical capabilities and its potential to expand access to specialized surgical care across geographic distances.
According to the company's announcement, the SSi Mantra will be showcased throughout the conference and included in multiple technical sessions. Chairman and CEO Dr. Sudhir Srivastava will participate in conference presentations covering telesurgery, the adoption of robotic surgery, and regulatory developments. The company noted that as of July 6, 2026, more than 12,375 procedures have been completed using the SSi Mantra system, including cardiac, pediatric, and telesurgical procedures. Approximately 2,100 physicians have been trained on the platform, which has been used across more than 170 different surgical procedures.
The SRS 2026 Annual Meeting provides a key platform for SS Innovations to demonstrate the clinical maturity and versatility of its surgical robotic system. The live telesurgery broadcast, in particular, underscores the company's focus on remote surgical capabilities, which could address disparities in access to minimally invasive surgery in underserved regions. As healthcare systems increasingly explore telemedicine and remote care models, the ability to perform surgeries remotely could represent a significant advancement in surgical care delivery.
Dr. Sudhir Srivastava, Chairman and CEO of SS Innovations, stated, "We are excited to bring the SSi Mantra to SRS 2026 and demonstrate its capabilities to the global robotic surgery community. The live telesurgery from India will highlight how our platform can enable surgeons to perform complex procedures remotely, potentially transforming access to surgical care." The company's participation in the conference also provides an opportunity to engage with potential partners and clinicians interested in adopting the technology.
The SSi Mantra system has been deployed in multiple surgical specialties, including urology, gynecology, cardiothoracic, and general surgery. The company's growing clinical experience, with over 12,000 procedures completed, supports its value proposition as a competitive alternative to established robotic surgical systems. The SRS 2026 Annual Meeting is expected to attract leading robotic surgeons, researchers, and industry stakeholders, offering SS Innovations a venue to showcase its technology and discuss future applications.
For more information about the SRS 2026 Annual Meeting, visit https://ibn.fm/FkgsY. Additional updates and news regarding SS Innovations International are available in the company's newsroom at https://ibn.fm/SSII.
This article contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause actual results to differ materially. Investors should consider the risk factors described in the company's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The company undertakes no obligation to update any forward-looking statements.
